Posted on 2/25/21
Medisafe Secures $30M in Series C
Medisafe, a leading digital therapeutics company creating digital drug companions, today announced that it has raised $30 million in Series C funding with investments led by . . .
Posted on 2/25/21
Cellarity Raises $123M in Series B
Cellarity, a life sciences company founded by Flagship Pioneering to develop a new method of drug discovery targeting the cell, announced today that it raised $123 . . .
Posted on 2/25/21
EMCOR Group Reports Fourth Quarter and Full-Year 2020 Results
NORWALK, Conn.--(BUSINESS WIRE)--EMCOR Group, Inc. (NYSE: EME) today reported results for the fourth quarter and year ended December 31, 2020.For the fourth quarter of 2020, net . . .
Posted on 2/25/21
HarbourVest Closes Real Assets Fund IV
BOSTON--(BUSINESS WIRE)--HarbourVest Partners, a global private markets asset manager, today announced the final close of Real Assets Fund IV, its latest infrastructure and real assets fund. The . . .
Posted on 2/25/21
MassMutual Launches $50 Million MM Catalyst Fund
SPRINGFIELD, Mass. & BOSTON--(BUSINESS WIRE)--Massachusetts Mutual Life Insurance Company (MassMutual) today announced the launch of the MM Catalyst Fund LLC (MMCF), a $50 million investment commitment . . .
Posted on 2/25/21
Commonwealth Appoints Karen McColl as SVP
Commonwealth Financial Network, a national firm dedicated to providing advisor-focused business solutions, announces the hiring of Karen McColl, CFA, SVP, wealth management.
Posted on 2/25/21
Boston Private Expands Miami Office
BOSTON--(BUSINESS WIRE)--Boston Private Financial Holdings, Inc. (NASDAQ: BPFH), a leading provider of integrated wealth management, trust, and banking services, today announced the expansion of its Miami, . . .
Posted on 2/25/21
Morten Bagai Joins GRAX Board of Directors
GRAX, the leading SaaS Data Value Platform, announced today that it has elected Morten Bagai to its board of directors. Bagai is the Chief Technology Officer . . .
Posted on 2/25/21
Monte Rosa Therapeutics Strengthens Leadership
BOSTON--(BUSINESS WIRE)--Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing proteins, announced today the promotion of Sharon Townson, Ph.D., . . .
Posted on 2/25/21
Bain Capital Specialty Finance Receives Investment from Moody’s
BOSTON--(BUSINESS WIRE)--Bain Capital Specialty Finance, Inc. (NYSE: BCSF) today announced that Moody’s Investors Service has assigned the Company with an investment grade rating of Baa3 and Stable . . .
Posted on 2/25/21
Wayfair Announces Fourth Quarter and Full Year 2020 Results
BOSTON--(BUSINESS WIRE)--Wayfair Inc. (NYSE: W), one of the world’s largest online destinations for the home, today reported financial results for its fourth quarter and full year . . .
Posted on 2/25/21
American Tower Corporation Reports Fourth Quarter and Full Year 2020 Financial Results
BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) today reported financial results for the quarter and the full year ended December 31, 2020.Tom Bartlett, American Tower’s Chief Executive . . .
Posted on 2/25/21
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the . . .
Posted on 2/25/21
Talaris Therapeutics Appoints Four Vice Presidents
BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing an innovative method of allogeneic hematopoietic stem cell transplantation with the potential . . .
Posted on 2/25/21
Concert Pharmaceuticals Reports 2020 Financial Results and Provides Update on Clinical Programs
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the year ended December 31, 2020, and provided an update on its product pipeline.“As . . .
Posted on 2/25/21
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported . . .
Posted on 2/25/21
Acushnet Holdings Corp. Announces Fourth Quarter and Full Year 2020 Financial Results
FAIRHAVEN, Mass.--(BUSINESS WIRE)--Acushnet Holdings Corp. (NYSE:GOLF) published its fourth quarter and full year 2020 financial results on February 25, 2021. The results are available via the . . .
Posted on 2/25/21
Karuna Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides General Business Update
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today . . .
Posted on 2/25/21
Great Hill Partners Joins $90M Series C for Terminus
Terminus, the leading account-based marketing platform, announced today it raised a $90 million Series C from Boston-based Great Hill Partners with participation from existing
Posted on 2/25/21
States That Had the Quickest Recovery of Weekly Unemployment Claims – Updated WalletHub Study
Despite the fact that the COVID-19 pandemic still has a strong grip on the U.S., new unemployment claims decreased week-over-week on February 15, and were 89% . . .
Posted on 2/25/21
Cue Biopharma Appoints Dr. Abul K. Abbas and Dr. Michael Kalos to Scientific Advisory Board
Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted
Posted on 2/25/21
Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update
BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare pediatric liver disease company developing novel bile acid modulators, today provided . . .
Posted on 2/25/21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and genetically . . .
Posted on 2/25/21
Radius Health Fourth Quarter and Full Year Results
BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today reported its financial results for the fourth quarter ended December 31, 2020 as . . .
Posted on 2/25/21
DraftKings Appoints Cal Ripken Jr. as Special Advisor to the Board of Directors
BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Today, DraftKings (Nasdaq: DKNG) announced the appointment of baseball legend and entrepreneur Cal Ripken Jr. as a special advisor . . .
Boston
